Final Settlement in Blood Reagents Antitrust Litigation Approved by Court

On October 24, 2018, in In re Blood Reagents Antitrust Litigation, a nation-wide price-fixing case against the major U.S. suppliers of blood reagents, in which SRK was appointed Class Counsel for direct purchaser plaintiffs, e.g., American Red Cross, hospitals, blood banks, labs, U.S. District Court Judge Jan DuBois (E.D. Pa.) gave final approval to a settlement with defendant Ortho-Clinical Diagnostics, Inc. totaling $19.5 million.  Combined with the previously approved settlement with defendant Immucor, Inc., SRK achieved settlements totaling $41.5 million for direct purchasers of traditional blood reagents, a medical necessity.  This settlement concludes the litigation, which has been pending since May 2009.  Judge DuBois praised SRK’s efforts, noting that the “lawyering in this case was nothing short of superb,” and that SRK partner Jeffrey Corrigan’s work was “excellent” and made Judge DuBois’ job “so much easier.”

This article was originally published under the firm’s former name, Spector Roseman & Kodroff, P.C. (“SRK”). The firm is now known as Spector Caldes & Corrigan, PC (“SCC”).

More News & Views